[ET Net News Agency, 23 April 2018] China Traditional Chinese Medicine (00570) said,
sponsored by the Chinese Journal of practical Pediatrics and the Chinese traditional
Medicine Association, "inheriting the Classics," the randomized, double-blind, positive
and placebo-controlled, multi-centered clinical trial (RCT) results of the efficacy and
safety of Yupingfeng Granules in the treatment of recurrent respiratory tract infections
in children were announced in Beijing.
The results showed that the efficacy of Yuping Feng Granules in the treatment of
recurrent respiratory tract infection in children was non-inferior to the positive control
group, and superior to the placebo group, and the risk of having respiratory tract
infection was significantly reduced by Yuping Feng Granules compared with placebo. In the
course of clinical study, there was no adverse events occurred during the study and the
clinical safety was high.
This study is the first clinical study on the treatment of recurrent respiratory tract
infection in pediatrics in accordance with the GCP standard. It will promote the
evidence-based development of Chinese medicine and set up a model of evidence-based
research in the field of traditional Chinese medicine in China. The results of RCT further
clarify the clinical value of Yuping Feng Granules and provide reliable and high quality
treatment plan for doctors. It is of positive significance to expand the sales of
Yupingfeng Granules in hospital. (HL)